Dyne Therapeutics 40% Rally Faces Fund Selloff Questions
A dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
Discover the 7 essential steps in financial planning to guide you towards financial security. Begin your planning journey now.
21,169 articlesA dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
A high-profile hedge fund billionaire made bold moves, piling into Amazon and Microsoft while slashing a top AI stock...
New York moves toward banning potassium bromate in flour, potentially altering crusts and prices for thousands of piz...
Perceptic, a London-founded startup formed by former Palantir Life Sciences executives, launches from stealth with a ...
IBM stock surged, led by advances in quantum computing and open-source software. This in-depth look explains what spu...
A boutique fund recently boosted its Innoviva stake by $2.5 million, raising questions about the stock's modest 10% g...
A strategic BTC sale and easing ETF inflows pushed Bitcoin to a two-month low. This article breaks down what happened...
Cardano teams with Brazil's Olympic Committee to modernize sports administration using AI, blockchain, and IoT. ADA r...
President Donald Trump retreats on appointing Bill Pulte to a key national security post after bipartisan Senate oppo...
MetaMask steps into the AI era with an agent wallet designed for self-custody and safer automated DeFi trading. This ...
A security researcher leveraged Claude-powered tooling to reveal a long-standing vulnerability in Zcash's Orchard cir...
Choosing between SPGM and IEFA depends on your goals: total-global exposure or a focus on developed markets outside N...